Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model
暂无分享,去创建一个
D. Harlan | D. Greiner | N. Walsh | Clinton W. Hupple | Agata Jurczyk | Chaoxing Yang | R. Bortell | Frederick R Roberts | Elaine Norowski | Natalia Przewozniak | Ken-Edwin Aryee | Filia M Van Dessel | Chaoxing Yang | Ken‐Edwin Aryee
[1] J. Nyalwidhe,et al. Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes , 2015, PloS one.
[2] Ralph Weissleder,et al. Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients , 2015, Proceedings of the National Academy of Sciences.
[3] M. V. von Herrath,et al. Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890 , 2014, Diabetes.
[4] M. Atkinson,et al. New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation , 2014, Current Diabetes Reports.
[5] Olli Simell,et al. Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility , 2014, Diabetes.
[6] Oliver S. Burren,et al. A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes , 2014, Diabetes.
[7] Clive Wasserfall,et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings , 2013, Pediatric diabetes.
[8] M. Atkinson. Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora’s box , 2014, Diabetologia.
[9] B. Edwin,et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study , 2014, Diabetologia.
[10] D. Harlan,et al. Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin , 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.
[11] D. Greiner,et al. Salicylate Prevents Virus-Induced Type 1 Diabetes in the BBDR Rat , 2013, PloS one.
[12] F. Urano,et al. Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes , 2013, Diabetologia.
[13] B. Croker,et al. Increased Complement Activation in Human Type 1 Diabetes Pancreata , 2013, Diabetes Care.
[14] Qibin Zhang,et al. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes , 2013, The Journal of experimental medicine.
[15] M. Atkinson,et al. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. , 2012, JAMA.
[16] M. Atkinson,et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes , 2012, Diabetes/metabolism research and reviews.
[17] M. Wilkins,et al. Children With Islet Autoimmunity and Enterovirus Infection Demonstrate a Distinct Cytokine Profile , 2012, Diabetes.
[18] M. Atkinson,et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.
[19] Chaoxing Yang,et al. The BB rat as a model of human type 1 diabetes. , 2012, Methods in molecular biology.
[20] D. Zipris. Innate immunity in type 1 diabetes , 2011, Diabetes/metabolism research and reviews.
[21] J. Leszyk,et al. Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats , 2010, Experimental biology and medicine.
[22] R. Planas,et al. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. , 2010, Immunology letters.
[23] Martin Vingron,et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk , 2010, Nature.
[24] Jeffrey A. Bluestone,et al. Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.
[25] D. Zipris. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. , 2009, Clinical immunology.
[26] D. Greiner,et al. Failure of alpha-galactosylceramide to prevent diabetes in virus-inducible models of type 1 diabetes in the rat. , 2009, In vivo.
[27] M. Rewers,et al. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. , 2008, Human molecular genetics.
[28] M. Hessner,et al. Identification of a Molecular Signature in Human Type 1 Diabetes Mellitus Using Serum and Functional Genomics1 , 2008, The Journal of Immunology.
[29] M. Rewers,et al. IFIH 1 polymorphisms are significantly associated with type 1 diabetes and IFIH 1 gene expression in peripheral blood mononuclear cells , 2008 .
[30] U. Boggi,et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients , 2007, Proceedings of the National Academy of Sciences.
[31] D. Clayton,et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region , 2006, Nature Genetics.
[32] S. Virtanen,et al. Environmental triggers and determinants of type 1 diabetes. , 2005, Diabetes.
[33] R. Weissleder,et al. Imaging inflammation of the pancreatic islets in type 1 diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. Wen,et al. The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets1 , 2004, The Journal of Immunology.
[35] D. Greiner,et al. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. , 2004, ILAR journal.
[36] J. Hillebrands,et al. Infections That Induce Autoimmune Diabetes in BBDR Rats Modulate CD4+CD25+ T Cell Populations12 , 2003, Journal of Immunology.
[37] M. Atkinson,et al. Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.
[38] D. Lombardo,et al. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. , 1999, Diabetes.
[39] D. Greiner,et al. Autoimmune Destruction of Islets Transplanted Into RT6-Depleted Diabetes-Resistant BB/Wor Rats , 1990, Diabetes.